Cohlhepp Ryan

President and COO, DirectorBicara Therapeutics Inc. (BCAX) · full profile →Form 4 · filed Jul 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$833K
Net Open-Market Flow
-$833K
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 9, 2026Sell(S)536$29.00$16K182K
Jul 8, 2026Option exercise(M)19K$3.79$71K210K
Jul 8, 2026Sell(S)23K$28.76$657K188K
Jul 8, 2026Sell(S)4K$29.80$128K183K
Jul 8, 2026Sell(S)1K$30.35$33K182K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 8, 2026Option exercise(M)19K$071K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001470831-26-000701) within minutes of acceptance. Every field above traces to the original document. Verify it directly: